{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:24:58Z","timestamp":1795040698960,"version":"4.10.2"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972967"],"award-info":[{"award-number":["81972967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271068"],"award-info":[{"award-number":["32271068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925031"],"award-info":[{"award-number":["81925031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108026"],"award-info":[{"award-number":["81820108026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202007030001"],"award-info":[{"award-number":["202007030001"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2020B1212060018"],"award-info":[{"award-number":["2020B1212060018"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2020B1212030004"],"award-info":[{"award-number":["2020B1212030004"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Project","award":["2019QN01Y202"],"award-info":[{"award-number":["2019QN01Y202"]}]},{"name":"The Science and Technology Planning Project of Guangdong Province","award":["2023B1212060018"],"award-info":[{"award-number":["2023B1212060018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alzheimer's disease (AD) is a neurodegenerative disorder and the predominant type of dementia worldwide. It is characterized by the progressive and irreversible decline of cognitive functions. In addition to the pathological beta-amyloid (A\u03b2) deposition, glial activation, and neuronal injury in the postmortem brains of AD patients, increasing evidence suggests that the often overlooked vascular dysfunction is an important early event in AD pathophysiology. Vascular endothelial growth factor (VEGF) plays a critical role in regulating physiological functions and pathological changes in blood vessels, but whether VEGF is involved in the early stage of vascular pathology in AD remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used an antiangiogenic agent for clinical cancer treatment, the humanized monoclonal anti-VEGF antibody bevacizumab, to block VEGF binding to its receptors in the 5\u00d7FAD mouse model at an early age. After treatment, memory performance was evaluated by a novel object recognition test, and cerebral vascular permeability and perfusion were examined by an Evans blue assay and blood flow scanning imaging analysis. Immunofluorescence staining was used to measure glial activation and A\u03b2 deposits. VEGF and its receptors were analyzed by enzyme-linked immunosorbent assay and immunoblotting. RNA sequencing was performed to elucidate bevacizumab-associated transcriptional signatures in the hippocampus of 5\u00d7FAD mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Bevacizumab treatment administered from 4\u00a0months of age dramatically improved cerebrovascular functions, reduced glial activation, and restored long-term memory in both sexes of 5\u00d7FAD mice. Notably, a sex-specific change in different VEGF receptors was identified in the cortex and hippocampus of 5\u00d7FAD mice. Soluble VEGFR1 was decreased in female mice, while full-length VEGFR2 was increased in male mice. Bevacizumab treatment reversed the altered expression of receptors to be comparable to the level in the wild-type mice. Gene Set Enrichment Analysis of transcriptomic changes revealed that bevacizumab effectively reversed the changes in the gene sets associated with blood\u2013brain barrier integrity and vascular smooth muscle contraction in 5\u00d7FAD mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study demonstrated the mechanistic roles of VEGF at the early stage of amyloidopathy and the protective effects of bevacizumab on cerebrovascular function and memory performance in 5\u00d7FAD mice. These findings also suggest the therapeutic potential of bevacizumab for the early intervention of AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40035-023-00388-4","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:02:18Z","timestamp":1704276138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-7325","authenticated-orcid":false,"given":"Wei-Jye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"4","key":"388_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-180141","volume":"64","author":"CR Beam","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M. Differences between women and men in incidence rates of dementia and alzheimer\u2019s disease. J Alzheimers Dis. 2018;64(4):1077\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"388_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"A Alzheimer's","year":"2016","unstructured":"Alzheimer\u2019s A. 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2016;12(4):459\u2013509.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"388_CR3","doi-asserted-by":"publisher","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","volume":"2","author":"R Tarawneh","year":"2012","unstructured":"Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med. 2012;2(5):a006148.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"388_CR4","doi-asserted-by":"publisher","first-page":"116974","DOI":"10.1016\/j.jns.2020.116974","volume":"416","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Kabir MT, Tewari D, Mamun AA, Mathew B, Aleya L, et al. Revisiting the role of brain and peripheral Abeta in the pathogenesis of Alzheimer\u2019s disease. J Neurol Sci. 2020;416:116974.","journal-title":"J Neurol Sci"},{"issue":"2","key":"388_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"issue":"3","key":"388_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137\u201352.","journal-title":"Nat Rev Neurol"},{"issue":"16","key":"388_CR7","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.3390\/ijms21165858","volume":"21","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, et al. Revisiting the amyloid cascade hypothesis: from anti-abeta therapeutics to auspicious new ways for Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(16):5858.","journal-title":"Int J Mol Sci"},{"key":"388_CR8","doi-asserted-by":"publisher","first-page":"101622","DOI":"10.1016\/j.arr.2022.101622","volume":"78","author":"MS Uddin","year":"2022","unstructured":"Uddin MS, Lim LW. Glial cells in Alzheimer\u2019s disease: from neuropathological changes to therapeutic implications. Ageing Res Rev. 2022;78:101622.","journal-title":"Ageing Res Rev"},{"key":"388_CR9","first-page":"69","volume":"7","author":"CY Santos","year":"2017","unstructured":"Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis. Alzheimers Dement. 2017;7:69\u201387.","journal-title":"Alzheimers Dement"},{"key":"388_CR10","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u20131695.","DOI":"10.1002\/alz.13016"},{"issue":"4","key":"388_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/brain\/awab387","volume":"145","author":"M Ali","year":"2022","unstructured":"Ali M, Falkenhain K, Njiru BN, Murtaza-Ali M, Ruiz-Uribe NE, Haft-Javaherian M, et al. VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer\u2019s mice. Brain. 2022;145(4):1449\u201363.","journal-title":"Brain"},{"issue":"10","key":"388_CR12","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV. The role of brain vasculature in neurodegenerative disorders. Nat Neurosci. 2018;21(10):1318\u201331.","journal-title":"Nat Neurosci"},{"issue":"2","key":"388_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11682-022-00750-6","volume":"17","author":"CG Swinford","year":"2023","unstructured":"Swinford CG, Risacher SL, Wu YC, Apostolova LG, Gao S, Bice PJ, et al. Altered cerebral blood flow in older adults with Alzheimer\u2019s disease: a systematic review. Brain Imaging Behav. 2023;17(2):223\u201356.","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"388_CR14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1148\/radiol.2503080751","volume":"250","author":"W Dai","year":"2009","unstructured":"Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology. 2009;250(3):856\u201366.","journal-title":"Radiology"},{"issue":"7","key":"388_CR15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/0271678X20982383","volume":"41","author":"O Bracko","year":"2021","unstructured":"Bracko O, Cruz Hernandez JC, Park L, Nishimura N, Schaffer CB. Causes and consequences of baseline cerebral blood flow reductions in Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2021;41(7):1501\u201316.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"388_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.7150\/thno.18509","volume":"7","author":"M Wiesmann","year":"2017","unstructured":"Wiesmann M, Zerbi V, Jansen D, Lutjohann D, Veltien A, Heerschap A, et al. Hypertension, cerebrovascular impairment, and cognitive decline in aged AbetaPP\/PS1 mice. Theranostics. 2017;7(5):1277\u201389.","journal-title":"Theranostics"},{"key":"388_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2009.12.020","volume":"1315","author":"S Heo","year":"2010","unstructured":"Heo S, Prakash RS, Voss MW, Erickson KI, Ouyang C, Sutton BP, et al. Resting hippocampal blood flow, spatial memory and aging. Brain Res. 2010;1315:119\u201327.","journal-title":"Brain Res"},{"issue":"4","key":"388_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3233\/JAD-130086","volume":"36","author":"DA Nation","year":"2013","unstructured":"Nation DA, Wierenga CE, Clark LR, Dev SI, Stricker NH, Jak AJ, et al. Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2013;36(4):689\u201398.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"388_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jalz.2016.08.013","volume":"13","author":"AE Leeuwis","year":"2017","unstructured":"Leeuwis AE, Benedictus MR, Kuijer JPA, Binnewijzend MAA, Hooghiemstra AM, Verfaillie SCJ, et al. Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(5):531\u201340.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"388_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/STROKEAHA.111.647982","volume":"43","author":"EJ Walker","year":"2012","unstructured":"Walker EJ, Su H, Shen F, Degos V, Amend G, Jun K, et al. Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke. 2012;43(7):1925\u201330.","journal-title":"Stroke"},{"issue":"6","key":"388_CR21","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6):1163\u201377.","journal-title":"J Cell Biol"},{"issue":"4","key":"388_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/rej.2006.9.485","volume":"9","author":"M Chiappelli","year":"2006","unstructured":"Chiappelli M, Borroni B, Archetti S, Calabrese E, Corsi MM, Franceschi M, et al. VEGF gene and phenotype relation with Alzheimer\u2019s disease and mild cognitive impairment. Rejuv Res. 2006;9(4):485\u201393.","journal-title":"Rejuv Res"},{"issue":"2","key":"388_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-170745","volume":"61","author":"R Harris","year":"2018","unstructured":"Harris R, Miners JS, Allen S, Love S. VEGFR1 and VEGFR2 in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61(2):741\u201352.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"388_CR24","doi-asserted-by":"publisher","first-page":"e86407","DOI":"10.1371\/journal.pone.0086407","volume":"9","author":"S Jiang","year":"2014","unstructured":"Jiang S, Xia R, Jiang Y, Wang L, Gao F. Vascular endothelial growth factors enhance the permeability of the mouse blood-brain barrier. PLoS ONE. 2014;9(2):e86407.","journal-title":"PLoS ONE"},{"issue":"4","key":"388_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/bpa.12331","volume":"26","author":"JS Miners","year":"2016","unstructured":"Miners JS, Palmer JC, Love S. Pathophysiology of hypoperfusion of the precuneus in early Alzheimer\u2019s disease. Brain Pathol. 2016;26(4):533\u201341.","journal-title":"Brain Pathol"},{"issue":"Pt 4","key":"388_CR26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/brain\/awv025","volume":"138","author":"T Thomas","year":"2015","unstructured":"Thomas T, Miners S, Love S. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer\u2019s disease and vascular dementia. Brain. 2015;138(Pt 4):1059\u201369.","journal-title":"Brain"},{"issue":"8","key":"388_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","volume":"12","author":"C Lange","year":"2016","unstructured":"Lange C, Storkebaum E, de Almodovar CR, Dewerchin M, Carmeliet P. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol. 2016;12(8):439\u201354.","journal-title":"Nat Rev Neurol"},{"key":"388_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02097-w","author":"F Qi","year":"2023","unstructured":"Qi F, Zuo Z, Hu K, Wang R, Wu T, Liu H, et al. VEGF-A in serum protects against memory impairment in APP\/PS1 transgenic mice by blocking neutrophil infiltration. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-023-02097-w","journal-title":"Mol Psychiatry."},{"issue":"4","key":"388_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","volume":"9","author":"M Shibuya","year":"2006","unstructured":"Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225\u201330 (discussion 231).","journal-title":"Angiogenesis"},{"issue":"3","key":"388_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/JAD-2012-120982","volume":"33","author":"SD Girard","year":"2013","unstructured":"Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, et al. Evidence for early cognitive impairment related to frontal cortex in the 5\u00d7FAD mouse model of Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33(3):781\u201396.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"388_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura R, Ohno M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5\u00d7FAD Alzheimer mouse model. Neurobiol Dis. 2009;33(2):229\u201335.","journal-title":"Neurobiol Dis"},{"issue":"40","key":"388_CR32","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"1","key":"388_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13041-020-00673-7","volume":"13","author":"SG Jeon","year":"2020","unstructured":"Jeon SG, Lee HJ, Park H, Han KM, Hoe HS. The VEGF inhibitor vatalanib regulates AD pathology in 5\u00d7FAD mice. Mol Brain. 2020;13(1):131.","journal-title":"Mol Brain"},{"issue":"5","key":"388_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3(5):391\u2013400.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"388_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12967-020-02212-3","volume":"18","author":"TG Simonsen","year":"2020","unstructured":"Simonsen TG, Gaustad JV, Rofstad EK. Bevacizumab treatment of meningeal melanoma metastases. J Transl Med. 2020;18(1):13.","journal-title":"J Transl Med"},{"issue":"10","key":"388_CR36","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-13-1941","volume":"20","author":"X Jiang","year":"2014","unstructured":"Jiang X, Engelbach JA, Yuan L, Cates J, Gao F, Drzymala RE, et al. Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain. Clin Cancer Res. 2014;20(10):2695\u2013702.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"388_CR37","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/nprot.2013.155","volume":"8","author":"M Leger","year":"2013","unstructured":"Leger M, Quiedeville A, Bouet V, Haelewyn B, Boulouard M, Schumann-Bard P, et al. Object recognition test in mice. Nat Protoc. 2013;8(12):2531\u20137.","journal-title":"Nat Protoc"},{"key":"388_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/0471142301.ns0831s69","volume":"69","author":"A Vogel-Ciernia","year":"2014","unstructured":"Vogel-Ciernia A, Wood MA. Examining object location and object recognition memory in mice. Curr Protoc Neurosci. 2014;69:8\u201331.","journal-title":"Curr Protoc Neurosci"},{"key":"388_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105\u201311.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"388_CR40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nprot.2018.034","volume":"13","author":"K Kisler","year":"2018","unstructured":"Kisler K, Lazic D, Sweeney MD, Plunkett S, El Khatib M, Vinogradov SA, et al. In vivo imaging and analysis of cerebrovascular hemodynamic responses and tissue oxygenation in the mouse brain. Nat Protoc. 2018;13(6):1377\u2013402.","journal-title":"Nat Protoc"},{"issue":"3","key":"388_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","volume":"22","author":"JC Cruz Hernandez","year":"2019","unstructured":"Cruz Hernandez JC, Bracko O, Kersbergen CJ, Muse V, Haft-Javaherian M, Berg M, et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models. Nat Neurosci. 2019;22(3):413\u201320.","journal-title":"Nat Neurosci"},{"issue":"2","key":"388_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.brainres.2005.02.044","volume":"1042","author":"R Kalayci","year":"2005","unstructured":"Kalayci R, Kaya M, Elmas I, Arican N, Ahishali B, Uzun H, et al. Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. Brain Res. 2005;1042(2):184\u201393.","journal-title":"Brain Res"},{"issue":"5","key":"388_CR43","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/brain\/awab050","volume":"144","author":"M Ries","year":"2021","unstructured":"Ries M, Watts H, Mota BC, Lopez MY, Donat CK, Baxan N, et al. Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology. Brain. 2021;144(5):1526\u201341.","journal-title":"Brain"},{"issue":"5","key":"388_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11357-019-00111-0","volume":"41","author":"A Csiszar","year":"2019","unstructured":"Csiszar A, Yabluchanskiy A, Ungvari A, Ungvari Z, Tarantini S. Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged mice. Geroscience. 2019;41(5):609\u201317.","journal-title":"Geroscience"},{"issue":"2","key":"388_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11357-020-00154-8","volume":"42","author":"A Yabluchanskiy","year":"2020","unstructured":"Yabluchanskiy A, Tarantini S, Balasubramanian P, Kiss T, Csipo T, Fulop GA, et al. Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation-induced impairment of neurovascular coupling responses protecting cognitive function in mice. Geroscience. 2020;42(2):409\u201328.","journal-title":"Geroscience"},{"key":"388_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yjmcc.2018.08.028","volume":"125","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Zhang M, Hu J, Lin J, Feng X, Wang S, et al. Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors. J Mol Cell Cardiol. 2018;125:117\u201328.","journal-title":"J Mol Cell Cardiol"},{"issue":"28","key":"388_CR47","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1523\/JNEUROSCI.0584-15.2015","volume":"35","author":"WJ Lin","year":"2015","unstructured":"Lin WJ, Jiang C, Sadahiro M, Bozdagi O, Vulchanova L, Alberini CM, et al. VGF and Its C-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-dependent mechanism. J Neurosci. 2015;35(28):10343\u201356.","journal-title":"J Neurosci"},{"issue":"6","key":"388_CR48","doi-asserted-by":"publisher","first-page":"194521","DOI":"10.1016\/j.bbagrm.2020.194521","volume":"1863","author":"A Lachmann","year":"2020","unstructured":"Lachmann A, Clarke DJB, Torre D, Xie Z, Ma\u2019ayan A. Interoperable RNA-Seq analysis in the cloud. Biochim Biophys Acta Gene Regul Mech. 2020;1863(6):194521.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"388_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"388_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"6","key":"388_CR51","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/bib\/bby067","volume":"20","author":"A McDermaid","year":"2019","unstructured":"McDermaid A, Monier B, Zhao J, Liu B, Ma Q. Interpretation of differential gene expression results of RNA-seq data: review and integration. Brief Bioinform. 2019;20(6):2044\u201354.","journal-title":"Brief Bioinform"},{"key":"388_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neunet.2019.05.020","volume":"118","author":"JX Mi","year":"2019","unstructured":"Mi JX, Zhang YN, Lai Z, Li W, Zhou L, Zhong F. Principal component analysis based on nuclear norm minimization. Neural Netw. 2019;118:1\u201316.","journal-title":"Neural Netw"},{"key":"388_CR53","doi-asserted-by":"publisher","first-page":"712576","DOI":"10.3389\/fnmol.2021.712576","volume":"14","author":"YE Yoo","year":"2021","unstructured":"Yoo YE, Lee S, Kim W, Kim H, Chung C, Ha S, et al. Early chronic memantine treatment-induced transcriptomic changes in wild-type and Shank2-mutant mice. Front Mol Neurosci. 2021;14:712576.","journal-title":"Front Mol Neurosci"},{"issue":"36","key":"388_CR54","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929\u201347.","journal-title":"J Neurosci"},{"key":"388_CR55","doi-asserted-by":"publisher","first-page":"e33670","DOI":"10.7554\/eLife.33670","volume":"7","author":"P Reeson","year":"2018","unstructured":"Reeson P, Choi K, Brown CE. VEGF signaling regulates the fate of obstructed capillaries in mouse cortex. Elife. 2018;7:e33670.","journal-title":"Elife"},{"key":"388_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2016.01.001","volume":"88","author":"P Giannoni","year":"2016","unstructured":"Giannoni P, Arango-Lievano M, Neves ID, Rousset MC, Baranger K, Rivera S, et al. Cerebrovascular pathology during the progression of experimental Alzheimer\u2019s disease. Neurobiol Dis. 2016;88:107\u201317.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"388_CR57","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00022.2020","volume":"101","author":"J Claassen","year":"2021","unstructured":"Claassen J, Thijssen DHJ, Panerai RB, Faraci FM. Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol Rev. 2021;101(4):1487\u2013559.","journal-title":"Physiol Rev"},{"issue":"4","key":"388_CR58","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.neuroimage.2005.06.066","volume":"28","author":"K Hirao","year":"2005","unstructured":"Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, et al. The prediction of rapid conversion to Alzheimer\u2019s disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage. 2005;28(4):1014\u201321.","journal-title":"Neuroimage"},{"issue":"1","key":"388_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3233\/JAD-160201","volume":"54","author":"W Lou","year":"2016","unstructured":"Lou W, Shi L, Wong A, Chu WC, Mok VC, Wang D. Changes of cerebral perfusion and functional brain network organization in patients with mild cognitive impairment. J Alzheimers Dis. 2016;54(1):397\u2013409.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"388_CR60","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1161\/CIRCULATIONAHA.117.027448","volume":"136","author":"FJ Wolters","year":"2017","unstructured":"Wolters FJ, Zonneveld HI, Hofman A, van der Lugt A, Koudstaal PJ, Vernooij MW, et al. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136(8):719\u201328.","journal-title":"Circulation"},{"issue":"4","key":"388_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11357-017-9980-z","volume":"39","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Fulop GA, Kiss T, Farkas E, Zolei-Szenasi D, Galvan V, et al. Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer\u2019s disease using functional laser speckle contrast imaging. Geroscience. 2017;39(4):465\u201373.","journal-title":"Geroscience"},{"issue":"5","key":"388_CR62","doi-asserted-by":"publisher","first-page":"e00655","DOI":"10.1002\/prp2.655","volume":"8","author":"L Froese","year":"2020","unstructured":"Froese L, Dian J, Gomez A, Unger B, Zeiler FA. The cerebrovascular response to norepinephrine: a scoping systematic review of the animal and human literature. Pharmacol Res Perspect. 2020;8(5):e00655.","journal-title":"Pharmacol Res Perspect"},{"issue":"8","key":"388_CR63","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/brain\/awab111","volume":"144","author":"N Holland","year":"2021","unstructured":"Holland N, Robbins TW, Rowe JB. The role of noradrenaline in cognition and cognitive disorders. Brain. 2021;144(8):2243\u201356.","journal-title":"Brain"},{"issue":"3","key":"388_CR64","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41380-019-0437-x","volume":"26","author":"HIL Jacobs","year":"2021","unstructured":"Jacobs HIL, Riphagen JM, Ramakers I, Verhey FRJ. Alzheimer\u2019s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms. Mol Psychiatry. 2021;26(3):897\u2013906.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"388_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/alzrt175","volume":"5","author":"T Chalermpalanupap","year":"2013","unstructured":"Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, et al. Targeting norepinephrine in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Res Ther. 2013;5(2):21.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"388_CR66","first-page":"BR215","volume":"10","author":"A Kraut","year":"2004","unstructured":"Kraut A, Barbiro-Michaely E, Mayevsky A. Differential effects of norepinephrine on brain and other less vital organs detected by a multisite multiparametric monitoring system. Med Sci Monit. 2004;10(7):BR215-220.","journal-title":"Med Sci Monit"},{"issue":"2","key":"388_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/ajplegacy.1976.231.2.489","volume":"231","author":"ET MacKenzie","year":"1976","unstructured":"MacKenzie ET, McCulloch J, Harper AM. Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiol. 1976;231(2):489\u201394.","journal-title":"Am J Physiol"},{"key":"388_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2017.08.012","volume":"182","author":"M Li","year":"2018","unstructured":"Li M, Kroetz DL. Bevacizumab-induced hypertension: clinical presentation and molecular understanding. Pharmacol Ther. 2018;182:152\u201360.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"388_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jash.2018.03.008","volume":"12","author":"RM Touyz","year":"2018","unstructured":"Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens. 2018;12(6):409\u201325.","journal-title":"J Am Soc Hypertens"},{"issue":"1 Suppl 1","key":"388_CR70","first-page":"S18","volume":"51","author":"C Geula","year":"1998","unstructured":"Geula C. Abnormalities of neural circuitry in Alzheimer\u2019s disease: hippocampus and cortical cholinergic innervation. Neurology. 1998;51(1 Suppl 1):S18-29 (discussion S65\u201317).","journal-title":"Neurology"},{"issue":"5","key":"388_CR71","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awac472","volume":"146","author":"A Maruszak","year":"2023","unstructured":"Maruszak A, Silajdzic E, Lee H, Murphy T, Liu B, Shi L, et al. Predicting progression to Alzheimer\u2019s disease with human hippocampal progenitors exposed to serum. Brain. 2023;146(5):2045\u201358.","journal-title":"Brain"},{"key":"388_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"AM Colangelo","year":"2014","unstructured":"Colangelo AM, Alberghina L, Papa M. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett. 2014;565:59\u201364.","journal-title":"Neurosci Lett"},{"issue":"1","key":"388_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry. 2021;11(1):27.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"388_CR74","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat Neurosci. 2020;23(6):701\u20136.","journal-title":"Nat Neurosci"},{"issue":"4","key":"388_CR75","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"key":"388_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2013.06.031","volume":"550","author":"L Huang","year":"2013","unstructured":"Huang L, Jia J, Liu R. Decreased serum levels of the angiogenic factors VEGF and TGF-beta1 in Alzheimer\u2019s disease and amnestic mild cognitive impairment. Neurosci Lett. 2013;550:60\u20133.","journal-title":"Neurosci Lett"},{"issue":"2","key":"388_CR77","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pnpbp.2012.02.010","volume":"38","author":"YN Kim","year":"2012","unstructured":"Kim YN, Kim DH. Decreased serum angiogenin level in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38(2):116\u201320.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"388_CR78","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0404.2006.00775.x","volume":"116","author":"I Mateo","year":"2007","unstructured":"Mateo I, Llorca J, Infante J, Rodriguez-Rodriguez E, Fernandez-Viadero C, Pena N, et al. Low serum VEGF levels are associated with Alzheimer\u2019s disease. Acta Neurol Scand. 2007;116(1):56\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"388_CR79","doi-asserted-by":"publisher","first-page":"17713","DOI":"10.1038\/s41598-017-18042-1","volume":"7","author":"SJ Cho","year":"2017","unstructured":"Cho SJ, Park MH, Han C, Yoon K, Koh YH. VEGFR2 alteration in Alzheimer\u2019s disease. Sci Rep. 2017;7(1):17713.","journal-title":"Sci Rep"},{"key":"388_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neurobiolaging.2021.07.015","volume":"107","author":"NM Tataryn","year":"2021","unstructured":"Tataryn NM, Singh V, Dyke JP, Berk-Rauch HE, Clausen DM, Aronowitz E, et al. Vascular endothelial growth factor associated dissimilar cerebrovascular phenotypes in two different mouse models of Alzheimer\u2019s disease. Neurobiol Aging. 2021;107:96\u2013108.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"388_CR81","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/ATVBAHA.115.307032","volume":"36","author":"K Schossleitner","year":"2016","unstructured":"Schossleitner K, Rauscher S, Groger M, Friedl HP, Finsterwalder R, Habertheuer A, et al. Evidence that cingulin regulates endothelial barrier function in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2016;36(4):647\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"388_CR82","doi-asserted-by":"publisher","first-page":"104067","DOI":"10.1016\/j.mvr.2020.104067","volume":"132","author":"K Zhuravleva","year":"2020","unstructured":"Zhuravleva K, Goertz O, Wolkart G, Guillemot L, Petzelbauer P, Lehnhardt M, et al. The tight junction protein cingulin regulates the vascular response to burn injury in a mouse model. Microvasc Res. 2020;132:104067.","journal-title":"Microvasc Res"},{"issue":"5","key":"388_CR83","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1073\/pnas.94.5.1852","volume":"94","author":"X Liu","year":"1997","unstructured":"Liu X, Wu H, Byrne M, Krane S, Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA. 1997;94(5):1852\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"388_CR84","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.mbplus.2021.100090","volume":"12","author":"R Omar","year":"2021","unstructured":"Omar R, Malfait F, Van Agtmael T. Four decades in the making: collagen III and mechanisms of vascular Ehlers Danlos syndrome. Matrix Biol Plus. 2021;12:100090.","journal-title":"Matrix Biol Plus"},{"issue":"21","key":"388_CR85","doi-asserted-by":"publisher","first-page":"8317","DOI":"10.3390\/ijms21218317","volume":"21","author":"RR Starks","year":"2020","unstructured":"Starks RR, Abu Alhasan R, Kaur H, Pennington KA, Schulz LC, Tuteja G. Transcription factor PLAGL1 is associated with angiogenic gene expression in the placenta. Int J Mol Sci. 2020;21(21):8317.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"388_CR86","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.peptides.2006.05.016","volume":"27","author":"Y Abdallah","year":"2006","unstructured":"Abdallah Y, Ross G, Dolf A, Heinemann MP, Schluter KD. N-terminal parathyroid hormone-related peptide hyperpolarizes endothelial cells and causes a reduction of the coronary resistance of the rat heart via endothelial hyperpolarization. Peptides. 2006;27(11):2927\u201334.","journal-title":"Peptides"},{"issue":"9","key":"388_CR87","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nm753","volume":"8","author":"MM Bakre","year":"2002","unstructured":"Bakre MM, Zhu Y, Yin H, Burton DW, Terkeltaub R, Deftos LJ, et al. Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor. Nat Med. 2002;8(9):995\u20131003.","journal-title":"Nat Med"},{"issue":"1","key":"388_CR88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/mmr.2016.6017","volume":"15","author":"L Feng","year":"2017","unstructured":"Feng L, Shu Y, Wu Q, Liu T, Long H, Yang H, et al. EphA4 may contribute to microvessel remodeling in the hippocampal CA1 and CA3 areas in a mouse model of temporal lobe epilepsy. Mol Med Rep. 2017;15(1):37\u201346.","journal-title":"Mol Med Rep"},{"issue":"5","key":"388_CR89","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/stem.427","volume":"28","author":"Y Hara","year":"2010","unstructured":"Hara Y, Nomura T, Yoshizaki K, Frisen J, Osumi N. Impaired hippocampal neurogenesis and vascular formation in ephrin-A5-deficient mice. Stem Cells. 2010;28(5):974\u201383.","journal-title":"Stem Cells"},{"issue":"7","key":"388_CR90","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1074\/jbc.M808786200","volume":"284","author":"YSM Mederos","year":"2009","unstructured":"Mederos YSM, Rinne S, Skrobek L, Renigunta V, Schlichthorl G, Derst C, et al. Mutation of histidine 105 in the T1 domain of the potassium channel Kv2.1 disrupts heteromerization with Kv6.3 and Kv6.4. J Biol Chem. 2009;284(7):4695\u2013704.","journal-title":"J Biol Chem"},{"issue":"3","key":"388_CR91","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1113\/jphysiol.2008.165217","volume":"587","author":"A Moreno-Dominguez","year":"2009","unstructured":"Moreno-Dominguez A, Cidad P, Miguel-Velado E, Lopez-Lopez JR, Perez-Garcia MT. De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain. J Physiol. 2009;587(3):625\u201340.","journal-title":"J Physiol"},{"issue":"5","key":"388_CR92","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/bib\/bbr042","volume":"12","author":"P Gaudet","year":"2011","unstructured":"Gaudet P, Livstone MS, Lewis SE, Thomas PD. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief Bioinform. 2011;12(5):449\u201362.","journal-title":"Brief Bioinform"},{"issue":"4","key":"388_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tem.2011.12.003","volume":"23","author":"A Schaffler","year":"2012","unstructured":"Schaffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab. 2012;23(4):194\u2013204.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"388_CR94","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awac472","volume":"146","author":"A Maruszak","year":"2023","unstructured":"Maruszak A, Silajdzic E, Lee H, Murphy T, Liu B, Shi L, et al. Predicting progression to Alzheimer\u2019s disease with human hippocampal progenitors exposed to serum. Brain. 2023;146(5):2045\u201358.","journal-title":"Brain"},{"issue":"5","key":"388_CR95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cytogfr.2014.05.002","volume":"25","author":"MS Diamond","year":"2014","unstructured":"Diamond MS. IFIT1: a dual sensor and effector molecule that detects non-2\u2032-O methylated viral RNA and inhibits its translation. Cytokine Growth Factor Rev. 2014;25(5):543\u201350.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"43","key":"388_CR96","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"388_CR97","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/0271678X19873658","volume":"40","author":"O Bracko","year":"2020","unstructured":"Bracko O, Njiru BN, Swallow M, Ali M, Haft-Javaherian M, Schaffer CB. Increasing cerebral blood flow improves cognition into late stages in Alzheimer\u2019s disease mice. J Cereb Blood Flow Metab. 2020;40(7):1441\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"388_CR98","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1177\/0271678X20964233","volume":"41","author":"D Liu","year":"2021","unstructured":"Liu D, Ahmet I, Griess B, Tweedie D, Greig NH, Mattson MP. Age-related impairment of cerebral blood flow response to K(ATP) channel opener in Alzheimer\u2019s disease mice with presenilin-1 mutation. J Cereb Blood Flow Metab. 2021;41(7):1579\u201391.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"388_CR99","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12868-018-0465-5","volume":"19","author":"O Shabir","year":"2018","unstructured":"Shabir O, Berwick J, Francis SE. Neurovascular dysfunction in vascular dementia, Alzheimer\u2019s and atherosclerosis. BMC Neurosci. 2018;19(1):62.","journal-title":"BMC Neurosci"},{"issue":"1","key":"388_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/WAD.0b013e3181b4f736","volume":"24","author":"LL Chao","year":"2010","unstructured":"Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord. 2010;24(1):19\u201327.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"388_CR101","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/nsr\/nwz124","volume":"6","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yin X, Zhang J, Li A, Gong H, Luo Q, et al. High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer\u2019s disease mice. Natl Sci Rev. 2019;6(6):1223\u201338.","journal-title":"Natl Sci Rev"},{"key":"388_CR102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","volume":"45","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ, Jansen JFA, van Osch MJP, van Buchem MA, Muller M, Wong SM, et al. Neurovascular unit impairment in early Alzheimer\u2019s disease measured with magnetic resonance imaging. Neurobiol Aging. 2016;45:190\u20136.","journal-title":"Neurobiol Aging"},{"key":"388_CR103","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fnagi.2014.00030","volume":"6","author":"KO Garcia","year":"2014","unstructured":"Garcia KO, Ornellas FL, Martin PK, Patti CL, Mello LE, Frussa-Filho R, et al. Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:30.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"388_CR104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jconrel.2013.04.028","volume":"170","author":"E Herran","year":"2013","unstructured":"Herran E, Perez-Gonzalez R, Igartua M, Pedraz JL, Carro E, Hernandez RM. VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP\/Ps1 mouse model of Alzheimer\u2019s disease. J Control Release. 2013;170(1):111\u20139.","journal-title":"J Control Release"},{"key":"388_CR105","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.ebiom.2021.103503","volume":"71","author":"CSB Singh","year":"2021","unstructured":"Singh CSB, Choi KB, Munro L, Wang HY, Pfeifer CG, Jefferies WA. Reversing pathology in a preclinical model of Alzheimer\u2019s disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. EBioMedicine. 2021;71:103503.","journal-title":"EBioMedicine"},{"issue":"20","key":"388_CR106","first-page":"4593","volume":"57","author":"LG Presta","year":"1997","unstructured":"Presta LG, Chen H, O\u2019Connor SJ, Chisholm V, Meng YG, Krummen L, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 1997;57(20):4593\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"388_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11060-017-2410-3","volume":"133","author":"C Duan","year":"2017","unstructured":"Duan C, Perez-Torres CJ, Yuan L, Engelbach JA, Beeman SC, Tsien CI, et al. Can anti-vascular endothelial growth factor antibody reverse radiation necrosis? A preclinical investigation. J Neurooncol. 2017;133(1):9\u201316.","journal-title":"J Neurooncol"},{"issue":"10","key":"388_CR108","doi-asserted-by":"publisher","first-page":"13361","DOI":"10.1096\/fj.202000365RR","volume":"34","author":"B He","year":"2020","unstructured":"He B, Wang X, He Y, Li H, Yang Y, Shi Z, et al. Gamma ray-induced glial activation and neuronal loss occur before the delayed onset of brain necrosis. FASEB J. 2020;34(10):13361\u201375.","journal-title":"FASEB J"},{"issue":"6","key":"388_CR109","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"F Bock","year":"2007","unstructured":"Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2007;48(6):2545\u201352.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"388_CR110","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1167\/iovs.07-1175","volume":"49","author":"L Yu","year":"2008","unstructured":"Yu L, Wu X, Cheng Z, Lee CV, LeCouter J, Campa C, et al. Interaction between bevacizumab and murine VEGF-A: a reassessment. Invest Ophthalmol Vis Sci. 2008;49(2):522\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"388_CR111","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour I, Pare I, Alata W, Coulombe K, Ringuette-Goulet C, Drouin-Ouellet J, et al. Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier. J Cereb Blood Flow Metab. 2013;33(12):1983\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"388_CR112","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.cell.2019.10.011","volume":"179","author":"O Beutel","year":"2019","unstructured":"Beutel O, Maraspini R, Pombo-Garcia K, Martin-Lemaitre C, Honigmann A. Phase separation of zonula occludens proteins drives formation of tight junctions. Cell. 2019;179(4):923\u201336.","journal-title":"Cell"},{"issue":"17","key":"388_CR113","doi-asserted-by":"publisher","first-page":"jcs258557","DOI":"10.1242\/jcs.258557","volume":"134","author":"S Holzner","year":"2021","unstructured":"Holzner S, Bromberger S, Wenzina J, Neumuller K, Holper TM, Petzelbauer P, et al. Phosphorylated cingulin localises GEF-H1 at tight junctions to protect vascular barriers in blood endothelial cells. J Cell Sci. 2021;134(17):jcs258557.","journal-title":"J Cell Sci"},{"issue":"7","key":"388_CR114","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.cell.2020.10.019","volume":"183","author":"S Boersma","year":"2020","unstructured":"Boersma S, Rabouw HH, Bruurs LJM, Pavlovic T, van Vliet ALW, Beumer J, et al. Translation and replication dynamics of single RNA viruses. Cell. 2020;183(7):1930\u201345.","journal-title":"Cell"},{"issue":"11","key":"388_CR115","doi-asserted-by":"publisher","first-page":"e22600","DOI":"10.1096\/fj.202200703RR","volume":"36","author":"S Saha","year":"2022","unstructured":"Saha S, Bose R, Chakraborty S, Ain R. Tipping the balance toward stemness in trophoblast: metabolic programming by Cox6B2. FASEB J. 2022;36(11):e22600.","journal-title":"FASEB J"},{"key":"388_CR116","doi-asserted-by":"publisher","first-page":"e58108","DOI":"10.7554\/eLife.58108","volume":"9","author":"CC Cheng","year":"2020","unstructured":"Cheng CC, Wooten J, Gibbs ZA, McGlynn K, Mishra P, Whitehurst AW. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma. Elife. 2020;9:e58108.","journal-title":"Elife"},{"key":"388_CR117","doi-asserted-by":"publisher","first-page":"156162","DOI":"10.1016\/j.cyto.2023.156162","volume":"164","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li H, Yu XH, Tang CK. CTRP1: a novel player in cardiovascular and metabolic diseases. Cytokine. 2023;164:156162.","journal-title":"Cytokine"},{"issue":"2","key":"388_CR118","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1182\/blood-2005-04-1425","volume":"107","author":"G Lasser","year":"2006","unstructured":"Lasser G, Guchhait P, Ellsworth JL, Sheppard P, Lewis K, Bishop P, et al. C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. Blood. 2006;107(2):423\u201330.","journal-title":"Blood"},{"issue":"11","key":"388_CR119","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s12276-021-00701-z","volume":"53","author":"SK Sonn","year":"2021","unstructured":"Sonn SK, Seo S, Yang J, Oh KS, Chen H, Chan DC, et al. ER-associated CTRP1 regulates mitochondrial fission via interaction with DRP1. Exp Mol Med. 2021;53(11):1769\u201380.","journal-title":"Exp Mol Med"},{"issue":"3","key":"388_CR120","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1096\/fj.15-279885","volume":"30","author":"D Yuasa","year":"2016","unstructured":"Yuasa D, Ohashi K, Shibata R, Mizutani N, Kataoka Y, Kambara T, et al. C1q\/TNF-related protein-1 functions to protect against acute ischemic injury in the heart. FASEB J. 2016;30(3):1065\u201375.","journal-title":"FASEB J"},{"issue":"8","key":"388_CR121","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1755-5949.2012.00340.x","volume":"18","author":"WY Liu","year":"2012","unstructured":"Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 2012;18(8):609\u201315.","journal-title":"CNS Neurosci Ther"},{"key":"388_CR122","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcdb.2020.12.011","volume":"116","author":"A Kapoor","year":"2021","unstructured":"Kapoor A, Nation DA. Role of notch signaling in neurovascular aging and Alzheimer\u2019s disease. Semin Cell Dev Biol. 2021;116:90\u20137.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"388_CR123","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pina-Crespo J, Li Y. Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"issue":"4","key":"388_CR124","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/157015911798376190","volume":"9","author":"SJ Allen","year":"2011","unstructured":"Allen SJ, Watson JJ, Dawbarn D. The neurotrophins and their role in Alzheimer\u2019s disease. Curr Neuropharmacol. 2011;9(4):559\u201373.","journal-title":"Curr Neuropharmacol"},{"issue":"11 Pt B","key":"388_CR125","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","volume":"1865","author":"BC Tong","year":"2018","unstructured":"Tong BC, Wu AJ, Li M, Cheung KH. Calcium signaling in Alzheimer\u2019s disease & therapies. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt B):1745\u201360.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"388_CR126","doi-asserted-by":"publisher","first-page":"105781","DOI":"10.1016\/j.nbd.2022.105781","volume":"171","author":"BR Troutwine","year":"2022","unstructured":"Troutwine BR, Strope TA, Franczak E, Lysaker CR, Hamid L, Mansel C, et al. Mitochondrial function and Abeta in Alzheimer\u2019s disease postmortem brain. Neurobiol Dis. 2022;171:105781.","journal-title":"Neurobiol Dis"},{"issue":"7483","key":"388_CR127","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman JR, Nunnari J. Mitochondrial form and function. Nature. 2014;505(7483):335\u201343.","journal-title":"Nature"},{"issue":"1","key":"388_CR128","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-023-00364-y","volume":"12","author":"L Xu","year":"2023","unstructured":"Xu L, Liu R, Qin Y, Wang T. Brain metabolism in Alzheimer\u2019s disease: biological mechanisms of exercise. Transl Neurodegener. 2023;12(1):33.","journal-title":"Transl Neurodegener"},{"key":"388_CR129","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-3-319-89689-2_11","volume":"20","author":"EM Lehmkuhl","year":"2018","unstructured":"Lehmkuhl EM, Zarnescu DC. Lost in translation: evidence for protein synthesis deficits in ALS\/FTD and related neurodegenerative diseases. Adv Neurobiol. 2018;20:283\u2013301.","journal-title":"Adv Neurobiol"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00388-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:03:03Z","timestamp":1704319383000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00388-4","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee of the Sun Yat-sen University (SYSU-IACUC-2021-000062) in conformity with the international guidelines on the ethics of animal experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}